S
Saikat Saha
Researcher at Linköping University
Publications - 50
Citations - 1245
Saikat Saha is an academic researcher from Linköping University. The author has contributed to research in topics: Particle filter & Estimation theory. The author has an hindex of 14, co-authored 46 publications receiving 1101 citations. Previous affiliations of Saikat Saha include Tokyo University of Science & Indian Institute of Science.
Papers
More filters
Journal ArticleDOI
Cytosolic Triacylglycerol Biosynthetic Pathway in Oilseeds. Molecular Cloning and Expression of Peanut Cytosolic Diacylglycerol Acyltransferase
TL;DR: The identified TAG biosynthetic activity was identified in the cytosolic fraction of developing peanut cotyledons and may present opportunities of bioengineering oil-yielding plants for increased oil production.
Journal ArticleDOI
Thirdhand smoke causes DNA damage in human cells
Bo Hang,Altaf H. Sarker,Christopher Havel,Saikat Saha,Tapas K. Hazra,Suzaynn F. Schick,Peyton Jacob,Virender K. Rehan,Ahmed Chenna,Divya Sharan,Mohamad Sleiman,Hugo Destaillats,Lara A. Gundel +12 more
TL;DR: It is demonstrated for the first time that exposure to THS is genotoxic in human cell lines, suggesting that THS exposure is related to increased oxidative stress and could be an important contributing factor in THS-mediated toxicity.
Journal ArticleDOI
ECG coding by wavelet-based linear prediction
A. G. Ramakrishnan,Saikat Saha +1 more
TL;DR: The significant feature of the proposed technique is that, while the error is nearly uniform throughout the cycle, the diagnostically crucial QRS region is kept free of maximal reconstruction error.
Journal ArticleDOI
Marginalized adaptive particle filtering for nonlinear models with unknown time-varying noise parameters
TL;DR: The MAPF is significantly more computationally efficient than a comparable particle filter that runs on the full augmented state and can handle sensor and actuator offsets as unknown means in the noise distributions, avoiding the standard approach of augmenting the state with such offsets.
Journal ArticleDOI
Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells
Warren Fiskus,Sunil Sharma,Saikat Saha,Bhavin Shah,Santhana G. T. Devaraj,Baohua Sun,Stephen Horrigan,Christopher Leveque,Youli Zu,Swaminathan P. Iyer,Kapil N. Bhalla +10 more
TL;DR: The pre-clinical anti-AML activity of the anthraquinone oxime-analog BC2059 (BC), known to attenuate β-catenin levels, is determined and this findings underscore the promising pre- clinical activity and warrant further testing of BC against human AML, especially those expressing FLT3-ITD.